Arafath K Najumudeen

13PUBLICATIONS
161CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineCancer cell biologyMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Jan 28, 2025
Spatial metabolomics to unravel cellular metabolism.

Arafath K Najumudeen, Johan Vande Voorde

|Nov 13, 2024
Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ.

Christos Kiourtis, Maria Terradas-Terradas, Lucy M Gee

|Oct 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition.

Sigrid K Fey, Arafath K Najumudeen, Dale M Watt

|Sep 12, 2024
SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers.

Johanna Lilja, Jasmin Kaivola, James R W Conway

|Jan 03, 2024
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.

Arafath K Najumudeen, Sigrid K Fey, Laura M Millett

Pageof 3

Frequent Collaborators

12 joint publications

Owen J Sansom

8 joint publications

Colin Nixon

8 joint publications

Andrew D Campbell

4 joint publications

Simon T Barry